🇪🇺 UPC
UPC_CFI_1940/2026
Court
Brussels Local Division
Type of action
revocation
Language
en
Claimant / applicant
- 2seventy bio, Inc.
Defendant / respondent
- Johnson & Johnson
- Janssen Biotech, Inc.
- Janssen Pharmaceuticals Inc.
- Janssen-Cilag International NV
- Janssen Pharmaceutica NV
- Janssen-Cilag NV
- Janssen Biologics B.V.
- Janssen-Cilag B.V.
- Janssen-Cilag GmbH
- Janssen-Cilag SAS
- Janssen-Cilag SpA
- Janssen-Cilag A/S
- Janssen-Cilag Aktiebolag
- Janssen-Cilag Farmaceutica Lda.
- Legend Biotech Corporation
Track this case
Get an email when a new order or decision is published in UPC_CFI_1940/2026.
Decisions and documents (1)
- 2026-06-15procedural
Counterclaim for revocation. Document: Procedural Order (R.37 RoP) UPC_CFI_029-2026 UPC_CFI_1934-2026 UPC_CFI_1940-2026.pdf. Case page: https://www.unifiedpatentcourt.org/en/node/183557
Weekly digest
A weekly email summarising new published decisions across European patent courts.